Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
Conditions
Interventions
None listed
Sponsors
Institute of Teaching and Research in Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Patients having at least three signs and symptoms of metabolic syndrome as per diagnostic criteria Patients willing to participate in the study
Exclusion criteria
Exclusion criteria: Patients currently on medication for Type 2 Diabetes Mellitus DM2 OR hypertension OR dyslipidaemia Patients with Endocrinal Obesity Patients with acute or chronic infections eg tuberculosis HIV hepatitis autoimmune or inflammatory disorders, malignancy or recent febrile illness within 4 weeks Patients who have received systemic corticosteroids for more than 7 days within the past 4 weeks immunosuppressive therapy within the past 8 weeks or regular use of non-steroidal anti inflammatory drugs NSAIDs within the past 2 weeks Pregnant and lactating women Patients who are unable to comply with the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relative downregulation in the expression of inflammation related genes NFKB1 RELA CHUK MMP9 TNF IL1B IL6 and GAPDH will be assessed before and after 90 days of interventionTimepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in subjective parameters of sthaulya Changes in anthropometric parameters Body weight BMI Waist circumference Changes in biological parameters Fasting blood sugar Triglycerides HDL Blood pressureTimepoint: 90 days | — |
Countries
India
Contacts
Public ContactProf Dr Darshna Pandya
Institute of Teaching and Research in Ayurveda, Jamnagar
Outcome results
None listed